Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Adam Folta"'
Autor:
Šárka Šestáková, Cyril Šálek, Dávid Kundrát, Ela Cerovská, Jan Vydra, Ivana Ježíšková, Adam Folta, Jiří Mayer, Petr Cetkovský, Hana Remešová
Publikováno v:
Clinical Epigenetics, Vol 16, Iss 1, Pp 1-12 (2024)
Abstract Background Changes in DNA methylation are common events in the pathogenesis of acute myeloid leukemia (AML) and have been repeatedly reported as associated with prognosis. However, studies integrating these numerous and potentially prognosti
Externí odkaz:
https://doaj.org/article/445a337be93740f6998ac1681e644cb8
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e81147 (2013)
As part of large protein complexes, Snf2 family ATPases are responsible for energy supply during chromatin remodeling, but the precise mechanism of action of many of these proteins is largely unknown. They influence many processes in plants, such as
Externí odkaz:
https://doaj.org/article/136df690cfc6433eb3b2d0ae139ea7ff
Autor:
Anna Durinikova, Adam Folta, Filip Pardy, Jan Svaton, Marie Drncova, Barbora Weinbergerova, Petr Cetkovsky, Zdenek Racil, Pavel Jindra, Tomas Szotkowski, Pavel Zak, Jiri Mayer, Ivana Jeziskova
Publikováno v:
Leukemia & Lymphoma. 63:3237-3240
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f511fa63cb5e24b65a6374a71eae14fa
https://doi.org/10.1080/10428194.2022.2116931
https://doi.org/10.1080/10428194.2022.2116931
Autor:
Daniela Zackova, Lukáš Semerád, Blanka Kubešová, Adam Folta, Jiri Mayer, Tomáš Jurček, Ivana Jeziskova
Publikováno v:
Leukemia & Lymphoma. 62:1239-1242
According to European Leukemia Network (ELN) recommendations, real-time quantitative PCR (qRT-PCR) is a conventional strategy for long-term BCR-ABL1 transcript monitoring in patients with chronic myeloid leukemia (CML) both during tyrosine kinase inh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d28b9ace940831b10dcf33677535aec5
https://doi.org/10.1080/10428194.2020.1861274
https://doi.org/10.1080/10428194.2020.1861274
Autor:
Šárka Šestáková, Ela Cerovská, Cyril Šálek, Dávid Kundrát, Ivana Ježíšková, Adam Folta, Jiří Mayer, Zdeněk Ráčil, Petr Cetkovský, Hana Remešová
Publikováno v:
Clinical Epigenetics. 14
Background Multiple studies have reported the prognostic impact of DNA methylation changes in acute myeloid leukemia (AML). However, these epigenetic markers have not been thoroughly validated and therefore are still not considered in clinical practi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::358870f48ae6776368c9e1820c81e0e1
https://doi.org/10.1186/s13148-022-01242-6
https://doi.org/10.1186/s13148-022-01242-6
Autor:
Adam Folta, Marketa Sasinkova, Anna Durinikova, Marie Drncova, Barbora Weinbergerova, Jiri Mayer, Ivana Jeziskova
Publikováno v:
Molecular biology reports. 49(8)
NPM1 plasmid standards are required for absolute quantification of minimal residual disease in acute myeloid leukemia patients. The standards are usually obtained, next to commercially constructed gene fragments, from transgenic bacteria colonies. Ho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::722ec300d401e524e8594f9b83c9f0b0
https://pubmed.ncbi.nlm.nih.gov/35716280
https://pubmed.ncbi.nlm.nih.gov/35716280
Autor:
Petr Cetkovský, Šárka Šestáková, Hana Remešová, Cyril Šálek, Zdeněk Krejčík, Zdeněk Ráčil, Pavla Pecherkova, Adam Folta, Jiří Mayer, Michaela Dostalova Merkerova, Ela Cerovska
Publikováno v:
Cancer Biomarkers. 25:43-51
Background Aberrant epigenetic patterns are a hallmark of acute myeloid leukemia (AML). Mutations in profound epigenetic regulators DNMT3A and IDH1/2 often occur concurrently in AML. Objectives The aim was to analyze DNA methylation, hydroxymethylati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8126606a0d916d6db3a2b2984deea376
https://doi.org/10.3233/cbm-182176
https://doi.org/10.3233/cbm-182176
Autor:
Adam, Folta, Tomas, Jurcek, Blanka, Kubesova, Daniela, Zackova, Lukas, Semerad, Jiri, Mayer, Ivana, Jeziskova
Publikováno v:
Leukemialymphoma. 62(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::85e9d8d996715164f5ef7631cb39f255
https://pubmed.ncbi.nlm.nih.gov/33356699
https://pubmed.ncbi.nlm.nih.gov/33356699
Autor:
Blanka, Robesova, Marie, Drncova, Adam, Folta, Marta, Krejci, Frantisek, Folber, Zuzana, Sustkova, Jiri, Mayer, Ivana, Jeziskova
Publikováno v:
Bone marrow transplantation. 55(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d8332568fdb0845cf660631f0ee01f8b
https://pubmed.ncbi.nlm.nih.gov/32388533
https://pubmed.ncbi.nlm.nih.gov/32388533
Autor:
Zdenek Racil, Ivana Jeziskova, Martin Čulen, Jiri Mayer, Nikola Tom, Jana Chovancová, Zdenka Kosarova, Tomáš Loja, Veronika Janečková, Adam Folta, Vojtech Bystry, Dana Dvorakova
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 144:1239-1251
This study aimed at analyzing the association of gene mutations and other acute myeloid leukemia (AML) characteristics with engraftment outcomes in immunodeficient mice and to select the engraftment outcomes that best reflect patient survival. Mutati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d16e86e8f080cc0bb7dfa37e35df6819
https://doi.org/10.1007/s00432-018-2652-2
https://doi.org/10.1007/s00432-018-2652-2